Publications by authors named "Manel Ferrer"

Claim this Profile
A
A prospective, international, bicentric study to evaluate PremiCron suture material for cardiac valve surgery - PREMIVALVE a cohort study.
Magdalena Rufa, Adrian Ursulescu, Petra Baumann, Manel T Ferrer

Ann Med Surg (Lond)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optilene, a new non-absorbable monofilament is safe and effective for CABG anastomosis. OPTICABG - A prospective international, multi-centric, cohort study.
Adrian Ursulescu, Petra Baumann, Manel Tauron Ferrer, Monica Contino, Claudia Romagnoni

Ann Med Surg (Lond)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Amino-7,8-dihydro-1,6-naphthyridin-5(6 H)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure-Activity Relationships.
Richard S Roberts, Sara Sevilla, Manel Ferrer, Joan Taltavull, Begoña Hernández

J Med Chem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure-Activity Relationships.
Jordi Gràcia, Maria Antonia Buil, Jordi Castro, Peter Eichhorn, Manel Ferrer

J Med Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists.
Maria Antonia Buil, Marta Calbet, Marcos Castillo, Jordi Castro, Cristina Esteve, Manel Ferrer

Eur J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of pyrrolopiperidinone acetic acids as CRTh2 antagonists.
Miriam Andrés, Maria Antonia Buil, Marta Calbet, Oscar Casado, Jordi Castro, Manel Ferrer

Bioorg Med Chem Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: lead optimization.
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Marta Calbet, Paul R Eastwood, Manel Ferrer

Bioorg Med Chem Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: the role of a hydrogen-bond acceptor in long receptor residence times.
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Manel Ferrer

Bioorg Med Chem Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists.
Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Marcos Castillo, Manel Ferrer

Eur J Med Chem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists.
Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Jordi Castro, Manel Ferrer

Bioorg Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis